| Literature DB >> 11418455 |
P C Spiegel1, M Jacquemin, J M Saint-Remy, B L Stoddard, K P Pratt.
Abstract
The development of an immune response to infused factor VIII is a complication affecting many patients with hemophilia A. Inhibitor antibodies bind to antigenic determinants on the factor VIII molecule and block its procoagulant activity. A patient-derived inhibitory immunoglobulin G4kappa antibody (BO2C11) produced by an immortalized memory B-lymphocyte cell line interferes with the binding of factor VIII to phospholipid surfaces and to von Willebrand factor. The structure of a Fab fragment derived from this antibody complexed with the factor VIII C2 domain was determined at 2.0 A resolution. The Fab interacts with solvent-exposed basic and hydrophobic side chains that form a membrane-association surface of factor VIII. This atomic resolution structure suggests a variety of amino acid substitutions in the C2 domain of factor VIII that might prevent the binding of anti-C2 inhibitor antibodies without significantly compromising the procoagulant functions of factor VIII.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11418455 DOI: 10.1182/blood.v98.1.13
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113